Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Total Hip Replacement
- Sponsor
- Anne Arundel Health System Research Institute
- Enrollment
- 75
- Locations
- 1
- Primary Endpoint
- Accuracy
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.
Detailed Description
This study is designed to be prospective randomized (1:1) controlled independent trial. Subjects are male and female, aged 18 and above, who are suitable candidates for either a unilateral (i.e. single) total hip replacement. Subjects that are scheduled with a single, extensively trained Physician Assistant assisting in their surgery will be exclusively included. This is single site study with projected enrollment of 150 subjects
Investigators
Paul King
Director of the Center for Joint Replacement
Anne Arundel Health System Research Institute
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Accuracy
Time Frame: Surgery
Primary objective is to determine the accuracy of the Butterfly IQ portable app based ultrasound device used in intra-articular hip injections determined by patient reported pain ratings using the Patient Reported Outcome Measure Information System (PROMIS) pain rating 0(no pain)- 5 (most pain)
Secondary Outcomes
- Blood Loss(Postoperative day 1)